Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625313 · ClinicalTrials.gov registry record · NA
Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens
A NA study, sponsored by Hoya Surgical Optics.
- Completed
- Registry status
- NA
- Development phase
- 617
- Enrollment target
NCT00625313 is a NA study that has completed, run by Hoya Surgical Optics. The registered enrollment target is 617 participants.
The verdict
NCT00625313, a NA study, has completed, sponsored by Hoya Surgical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 617 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) when implanted in the posterior chamber of the human eye for the optical correction of aphakia following cataract extraction.
Interventions
- DEVICE HMY Model YA-60BB IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 617 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625313
The ClinicalTrials.gov registry entry for NCT00625313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 617 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoya Surgical Optics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HMY Model YA-60BB IOL is the first listed.
NCT00625313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00625313 about?
NCT00625313 is a clinical study titled "Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens". The purpose of this study is to assess the safety and efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) when implanted in the posterior chamber of the human eye for the optical correction of aphakia following cataract extraction.
What is the current status of trial NCT00625313?
This trial is currently completed. It is a NA study. The enrollment target is 617 participants. The study started on 2004-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00625313?
The interventions under investigation include: HMY Model YA-60BB IOL (DEVICE).
Who is sponsoring clinical trial NCT00625313?
This trial is sponsored by Hoya Surgical Optics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.